BofA raised the firm’s price target on Bunge (BG) to $130 from $125 and keeps a Buy rating on the shares. The firm views Bunge’s Investor Day positively, given higher-than-expected midcycle EPS of $13-$15, an increase in the synergy target, and the discussion of additional margin-enhancing opportunities as the company leverages the combined platform and tech. The firm added that it believes the event was a hurdle that investors had to overcome for fear of a disappointing outlook, and now that the obstacle has passed, it believes the shares can power even higher.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
- Bunge price target raised to $140 from $130 at Morgan Stanley
- Bunge price target raised to $135 from $130 at BMO Capital
- Morning Movers: BioNTech sinks following departure of founders, Q4 results
- Bunge announces $3B share repurchase program
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
